Abbott Biaxin XL CAP Approval Supported By Levaquin Comparative Data
Executive Summary
Abbott's Biaxin XL is comparable to Johnson & Johnson's Levaquin for the treatment of community-acquired pneumonia, an Abbott study used to support Biaxin's application for the indication shows.